Are we overstating post-employment drug plan liabilities?
I don’t claim to be an actuary, but how can a simple formula provide an appropriate valuation of a company’s drug plan liability for dynamic…
- December 13, 2010 September 13, 2019
- 00:00
I don’t claim to be an actuary, but how can a simple formula provide an appropriate valuation of a company’s drug plan liability for dynamic…
Families cashing out could give venture cap a boost.
Why your assumptions about hedge fund fees are all wrong.
So long as people keep on dying, investors and operators will have steady cash flows into the distant future.
Mozambique, Malaysia, Egypt - all aboard the SWF train.
CRSP sets out a benchmark against front-running.
Diminished potential to generate higher returns.
Towers Watson recently held its annual U.K. client conference, bringing together clients, consultants and money managers to discuss topical issues. Delivered through a case-study environment,…
A gloomy glossary for shell-shocked investors.
China prepared to bail EU out, buy Irish banks.
How technology caused the consumption trap.
Need for good governance elephant in room.